![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Demand-Based Price Negotiations Proposed by Center for American Progress
Demand-Based Price Negotiations Proposed by Center for American Progress
October 3, 2016
The Center for American Progress has unveiled a plan to create a system for health care payers to negotiate prices based on the clinical benefits of a treatment.
The value-based system would grant health care payers—such as Medicare—leverage to negotiate lower prices without the need for policy amendments or drug formularies, according to the think tank.
The process would begin in the first three months of a drug’s approval. In those early months, the HHS secretary would be tasked with deciding whether to refer a drug to two certified research organizations for comparative efficacy reviews.
Upcoming Events
-
21Oct